Anesthesia for adult patients with congenital heart disease undergoing noncardiac surgery

International Anesthesiology Clinics

Volumn 39, Issue 4, 2001, Pages 43-71

  Galli, K K ^a   Myers, L B ^a   Nicolson, S C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANESTHESIA; AORTA COARCTATION; CONGENITAL HEART DISEASE; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART SINGLE VENTRICLE; HUMAN; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; SURGICAL RISK;

EID: 0034758515     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200110000-00006     Document Type: Review

References (54)

1. Influence of congenital heart disease on mortality after noncardiac surgery in hospitalized children
2. Outcomes of noncardiac surgical procedures in children and adults with congenital heart disease
3. Transcatheter closure of atrial septal defects using the Cardio-Seal implant
4. Comparison of results and complications of surgical and amplatzer device closure of atrial septal defects
5. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial)
6. Transesophageal echocardiography to evaluate success of transcatheter closure of large secundum atrial septal defects in adults using the buttoned device
7. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement
8. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events
9. Developmental outcome after surgical versus interventional closure of secundum atrial septal defects in children
10. Treatment options for coarctation of the aorta
11. Arterial hypertension in children and adolescents after surgical repair of aortic coarctation defined by ambulatory blood pressure monitoring
12. Initial results and clinical follow-up after balloon angioplasty for native coarctation
13. Stent treatment for coarctation of the aorta: Intermediate-term follow-up and technical considerations
14. Nonsurgical closure of patent ductus arteriosus: Clinical application of the rashkind PDA occluder system
15. Safety and efficacy of interventioal occlusion of patent ductus arteriosus with detachable coils: A multicentre trial
16. Long-term outcome of trancatheter coil closure of small to large patent ductus arteriosus
17. Recanalisation after coil embolisation of persistent ductus arteriosus
18. Residual and recurrent shunts after implantation of cook detachable duct occlusion coils
19. Radiation exposure to children during coil occlusion of the patent ductus arteriosus
20. Video-assisted thoracoscopic surgery for patent ductus arteriosus in low birth weight neonates and infants
21. Late follow-up after thoracoscopic duct ligation
22. Video-thoracoscopic surgical interruption of patent ductus arteriosus. Routine experience in 332 pediatric cases
23. Detection of residual flow by transesophageal echocardiography during video-assisted thoracoscopic patent ductus arteriosus interruption
24. The use of multiplane transesophageal echocardiography to evaluate residual patent ductus arteriosus during video-assisted thoracoscopy in adults
25. Percutaneous balloon dilatation of the atria septum: Immediate and midterm results
26. Role of balloon atrial septostomy before early arterial switch repair of transposition of the great arteries
27. Right ventricular systolic function in adolescents and young adults after Mustard operation for transposition of the great arteries
28. Arrhythmia and survival in patients >18 years of age after the Mustard procedure for complete transposition of the great arteries
29. Late complications and quality of life after atrial correction of transposition of the great arteries in 12- to 18-year follow-up
30. Twenty-five-year experience with Rastelli repair for transposition of the great arteries
31. Long-term fate of the coronary arteries after the arterial switch operation in newborns with transposition of the great arteries
32. Long-term outcome in congenitally-corrected transposition of the great arteries: A multi-institutional study
33. Corrected transposition of the great arteries without associated defects in adult patients: Clinical profile and follow-up
34. Tetralogy of fallot
35. The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia
36. Outcome of adults with repaired tetralogy of Fallot
37. Twenty- to thirty-seven-year follow-up after repair for tetralogy of Fallot
38. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings
39. Tetralogy of Fallot: What operation, at which age
40. Early age at repair prevents restrictive right ventricular (RV) physiology after surgery for tetralogy of Fallot (TOF): Diastolic RV function after TOF repair in infancy
41. Late functional status of survivors of the Fontan procedure performed during the 1970s
42. Five- to fifteen-year follow-up after Fontan operation
43. Results of the Fontan procedure for patients with univentricular heart
44. Exercise capacity and mid-term survival in patients with tricuspid atresia and complex congenital cardiac malformations after modified Fontan operation
45. Functional outcome after the Fontan operation: Factors influencing late morbidity
46. Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders
47. Heart transplantation in the pediatric age-group and for end-stage congenital heart defects
48. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease
49. Orthotopic cardiac transplantation for the failing Fontan circulation
50. Current results with pediatric heart transplantation
51. Intermediate and long-term results after pediatric heart transplantation: Incidence and role of pretransplant diagnosis
52. Cardiac transplantation for end-stage congenital heart defects: The Mayo Clinic experience
53. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
54. Psychosocial profile of adults with complex congenital heart disease